Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Bladder cancer, Blood cancers, Chronic leukaemia, Hodgkin lymphoma, Leukaemia, Lymphoma, Non-Hodgkin lymphoma (NHL), Testicular cancer
Closed
Phase 4
This trial is looking at a gel that contains the male hormone to see if it helps men who have low levels of testosterone after cancer treatment. The trial is supported by Cancer Research UK.
We know from research that men aged 25 to 50 who have had treatment for cancer may have lower levels of testosterone than other men. A low testosterone level may cause
An increase in body fat and weight gain
A reduced sex drive
A lower sense of general well being
Men who have very low levels of testosterone can have treatment to replace the hormone. But doctors are unsure of the best way to help men who have testosterone levels that are just a bit lower than normal. They call this a borderline low level.
The aim of this study is to see if a gel containing testosterone can help men with borderline low levels of testosterone following cancer treatment. The researchers want to see if it can help reduce body fat, and improve sex drive and general wellbeing.
Recruitment start: 30 May 2012
Recruitment end: 31 January 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Richard Ross
Cancer Research UK
Clinical Trials Research Unit (CTRU)
Experimental Cancer Medicines Centres (ECMC)
University of Leeds
NIHR Clinical Research Network:Â Cancer
ProStrakan
Sheffield Hospitals Charity
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield
This is Cancer Research UK trial number CRUK/10/012.
Last reviewed: 7 August 2016
CRUK internal database number: 2654